Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.4100
-0.02-3.94%
At close: -
$0.4028
-0.00720-1.76%
After Hours: 5:07 PM EDT
Comments
Loading...
CARISMA Therapeutics Stock Price, Quotes and Forecasts
CARMNASDAQ
CARISMA Therapeutics (CARM) Forecast
NewsEarningsCARISMA Therapeutics (CARM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
CARISMA Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CARM | Benzinga
Explore CARISMA Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CARM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CARISMA Therapeutics (CARM) stock?
You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.
Who are CARISMA Therapeutics (CARM) competitors?
Other companies in CARISMA Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Evaxion Biotech (NASDAQ:EVAX) and Nanoviricides (AMEX:NNVC).
What is the forecast, or price target, for CARISMA Therapeutics (CARM) stock?
CARISMA Therapeutics has a consensus price target of $9.54.
What is the current price for CARISMA Therapeutics (CARM)?
The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $0.4028 last updated February 27, 2025 at 5:07 PM EST.
Does CARISMA Therapeutics (CARM) pay a dividend?
There are no upcoming dividends for CARISMA Therapeutics.
When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?
CARISMA Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is CARISMA Therapeutics (CARM) going to split?
There is no upcoming split for CARISMA Therapeutics.
What sector and industry does CARISMA Therapeutics (CARM) operate in?
CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.